Point Capital, Inc. (42)
Browse by Contract Category
Contracts
-
Description of the Registrants Securities
(Filed With SEC on March 28, 2022)
-
Form of Stock Purchase Agreement
(Filed With SEC on September 27, 2021)
-
First Amendment to Commercial Evaluation and License Agreement, dated July 6, 2021, by and between the Company and UMB
(Filed With SEC on July 12, 2021)
-
Joint Venture Agreement, dated April 22, 2021, by and between the Company and Zyl Therapeutics, Inc
(Filed With SEC on April 28, 2021)
-
First Amendment to Employment Agreement, dated January 18, 2021, by and between the Company and Eric Weisblum
(Filed With SEC on January 28, 2021)
-
Form of Advisory Agreement, dated as of April 17, 2020
(Filed With SEC on April 22, 2020)
-
Form of Sponsored Research Agreement
(Filed With SEC on October 27, 2021)
-
Sponsored Research Agreement, dated July 6, 2021, by and between the Company and UMB
(Filed With SEC on July 12, 2021)
-
Sponsored Research Agreement, dated June 1, 2021, by and between the Company and UCSF
(Filed With SEC on June 7, 2021)
-
Amendment No. 1 to Patent License Agreement, dated April 12, 2021, by and among the Company, Silo Pharma, Inc. and AIkido Pharma Inc
(Filed With SEC on April 16, 2021)
-
Sublicense Agreement, dated April 6, 2021, by and between the Company and AIkido Pharma, Inc
(Filed With SEC on April 7, 2021)
-
Description of the Registrants Securities
(Filed With SEC on March 29, 2021)
-
Letter of Intent, dated February 12, 2021, by and between the Company and Aikido Pharma, Inc
(Filed With SEC on February 16, 2021)
-
Master License Agreement, dated February 12, 2021, by and between the Company and the University of Maryland, Baltimore
(Filed With SEC on February 16, 2021)
-
Form of Placement Agent Warrant
(Filed With SEC on February 12, 2021)
-
Form of Lock-Up Agreement, dated as of February 9, 2021
(Filed With SEC on February 10, 2021)
-
Form of Registration Rights Agreement, dated as of February 9, 2021, between Silo Pharma, Inc. and the signatories thereto
(Filed With SEC on February 10, 2021)
-
Form of Warrant
(Filed With SEC on February 10, 2021)
-
Form of Securities Purchase Agreement, dated as of February 9, 2021, between Silo Pharma, Inc. and the signatories thereto
(Filed With SEC on February 10, 2021)
-
Silo Pharma, Inc. 2020 Omnibus Equity Incentive Plan
(Filed With SEC on January 28, 2021)
-
Sponsored Research Agreement by and between the Company and the University of Maryland, Baltimore
(Filed With SEC on January 11, 2021)
-
Patent License Agreement by and among the Company and Silo Pharma, Inc., a Florida corporation and their affiliates and subsidiaries and AIkido Pharma Inc
(Filed With SEC on January 11, 2021)
-
Form of Registration Rights Agreement, dated as of April 28, 2020
(Filed With SEC on April 29, 2020)
-
Form of Securities Purchase Agreement, dated as of April 28, 2020
(Filed With SEC on April 29, 2020)
-
Form of Lock-Up Agreement, dated as of April 28, 2020
(Filed With SEC on April 29, 2020)
-
Form of Exchange Agreement for Convertible Notes, dated as of April 15, 2020
(Filed With SEC on April 22, 2020)
-
Form of Employment Agreement, dated as of April 17, 2020
(Filed With SEC on April 22, 2020)
-
Form of Consulting Agreement, dated as of April 17, 2020
(Filed With SEC on April 22, 2020)
-
Form of Subscription Agreement, dated as of April 17, 2020
(Filed With SEC on April 22, 2020)
-
Form of Exchange Agreement for Series B Preferred Stock, dated as of April 15, 2020
(Filed With SEC on April 22, 2020)
-
Form of Subscription Agreement, dated as of April 17, 2020
(Filed With SEC on April 21, 2020)
-
Form of Exchange Agreement for Convertible Notes, dated as of April 15, 2020
(Filed With SEC on April 21, 2020)
-
Form of Exchange Agreement for Series B Preferred Stock, dated as of April 15, 2020
(Filed With SEC on April 21, 2020)
-
Form of Employment Agreement, dated as of April 17, 2020
(Filed With SEC on April 21, 2020)
-
Form of Consulting Agreement, dated as of April 17, 2020
(Filed With SEC on April 21, 2020)
-
Form of Advisory Agreement, dated as of April 17, 2020
(Filed With SEC on April 21, 2020)
-
Form of Securities Purchase Agreement for the purchase of Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors
(Filed With SEC on March 20, 2020)
-
Form of registration rights agreement related to Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors
(Filed With SEC on March 20, 2020)
-
Form of Warrant related to Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors
(Filed With SEC on March 20, 2020)
-
Form of convertible note agreement with Investors
(Filed With SEC on November 13, 2019)
-
Form of Warrant
(Filed With SEC on November 13, 2019)
-
Form of Securities Purchase Agreement, dated October 2019, between Uppercut Brands, Inc., and Investors
(Filed With SEC on November 13, 2019)
